Please click here to register.
Opportunities abound for dealmakers who can navigate the ever-changing global life sciences deal landscape. However, the transformative transactions shaping today’s hottest life sciences growth sectors also can present new—and sometimes daunting—challenges for your organization. Join us for this one-day conference, now in its eighth year, focused on all aspects of dealmaking in the life sciences industry. New this year will be two afternoon tracks, one for investors and BD professionals, and the other for in-house counsel in the life sciences industry.
This “must attend” event will feature:
- Access to 300+ life sciences executives and investors
- Best practices from seasoned dealmakers, industry executives and technical experts
- Insight on the critical business, transactional and regulatory issues that impact investment growth and profitability
Registration Information
Date/Time:
October 15-16, 2019
Venue:
The Royal Sonesta
40 Edwin H Land Blvd,
Cambridge, MA 02142
View Map
Please click here to view the full agenda.
Speakers
 |
Scott Gottlieb, M.D.
23rd Commissioner of the Food & Drug Administration
Scott Gottlieb will join McDermott FDA Practice Co-Chair Vernessa Pollard for a lunchtime fireside chat.
Dr. Gottlieb’s work focuses on advancing public health through developing and implementing innovative approaches to improving medical outcomes, reshaping healthcare delivery, and expanding consumer choice and safety.
|
Sponsors
For more information and sponsorship opportunities, please contact Laura McAllister or Angus McQuilken.
Please click here to register.
